Answers are grounded in this paper and cite their sources.
Highlights the clinical dilemma of polypharmacy in managing advanced ischemic cardiomyopathy despite strong evidence for multiple medications.
Based on strong evidence, a patient with advanced ischemic cardiomyopathy should be taking nine medications. But it is difficult not to worry about polypharmacy.
No takes yet. Share an insight, caveat, or question.
Stehlik et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: